Leveljump Healthcare Begins Trading on TSXV

- December 14th, 2020

The Company has been approved for trading on the TSXV as a Tier 1 issuer.

Leveljump Healthcare Corp. (TSXV:JUMP) (“the “Company“), a Canadian leader in b2b telehealth solutions, is pleased to announce that trading of the Company’s common shares will commence today under the trading symbol “JUMP”, CUSIP #52731E106. The Company has been approved for trading on the TSXV as a Tier 1 issuer.

The Company also confirms, as per previous released updates, that it has closed on a concurrent financing that consisted of $3.9M of cash and $500,000 of debt conversion. Following the closing of the financing, the Company used part of the proceeds to retire a royalty interest that was owed by the Company’s operating subsidiary, Canadian Teleradiology Services, (“CTS”).

“Today is a very exciting day as we begin trading on the TSXV,” said Mitch Geisler, CEO. “With cash flow positive operations, a clean balance sheet and the support of the investment community, we look forward to growing the Company and executing our vision. Diagnostic Imaging is an invaluable part of our healthcare system and we have established ourselves at the forefront of this space, ensuring communities have the best patient care.”

The Company is also pleased to announce that its new website is now live at www.leveljumphealthcare.com.

About Leveljump Healthcare

Leveljump Healthcare Corp., (TSXV: JUMP) is building a national medical diagnostic imaging company and brand, primarily by providing Teleradiology (remote radiology) services to its client hospitals and imaging centers. Additionally, JUMP plans to expand through the acquisition of independent healthcare facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler, Chief Executive Officer
info@leveljumphealthcare.com
(877) 722-6965

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the Company’s business plans and the outlook of the Company’s industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

 

Source

  Life Science and Healthcare Investing report cover

Life Science and Healthcare Investing in 2021

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2021 life science outlook report!
 

Tags

Tags:

Leave a Reply